Ravenel Boykin Curry IV
Eagle Capital Management
Eagle Capital Management Humana Inc stake
total: 177
Eagle Capital Management HUM trades
- Total transactions:
- 10
- New positions:
- 1
- Added:
- 5
- Reduced:
- 4
- Held since:
- 2024 Q1
- Held for:
- 10 quarters
- Latest activity:
- 2026 Q2
According to 2026 Q2 report, Eagle Capital Management holds 3,846,762 Humana Inc (HUM) shares with a market value of roughly $1.53B accounting for 4.67% of the overall portfolio. To date, the estimated cost basis is nearly $352.47 for "buy" trades and estimated average "sell" price is $234.37. Eagle Capital Management first purchased HUM in 2024 Q1, initially acquiring 687,091 shares. Since the initial investment in Humana Inc (HUM), Eagle Capital Management has made 9 more transactions.
When did Eagle Capital Management buy Humana Inc (HUM)?
Eagle Capital Management first invested in Humana Inc (HUM) in 2024 Q1 at the reported quarter-end price of $346.72 per share.
What's the cost basis of Eagle Capital Management's HUM stake?
The estimated cost basis for Humana Inc (HUM) stake is around $352.47 per share. This represents their average reported price* across all buy transactions
Estimated cost basis*
- Weighted AVG buy price:
- $352.47
- Weighted AVG sell price:
- $234.37
Eagle Capital Management's historical trades in Humana Inc
10 results
| Period |
% of portfolio |
Shares held after* |
Reported price* |
Value* |
% (shares) of activity |
% change to portfolio |
|---|---|---|---|---|---|---|
|
2026 Q2
|
4.67%
|
3,846,762
|
$397.22
|
$1,528,010,749
|
+29.65% (+879,688)
|
+1.07%
|
|
2026 Q1
|
1.73%
|
2,967,074
|
$173.39
|
$514,460,967
|
-8.83% (-287,324)
|
-0.16%
|
|
2025 Q4
|
2.60%
|
3,254,398
|
$256.13
|
$833,548,871
|
-17.93% (-711,094)
|
-0.58%
|
|
2025 Q3
|
3.28%
|
3,965,492
|
$260.17
|
$1,031,702,025
|
+0.41% (+16,018)
|
+0.01%
|
|
2025 Q2
|
3.18%
|
3,949,474
|
$244.48
|
$965,567,351
|
+25.65% (+806,187)
|
+0.65%
|
|
2025 Q1
|
3.03%
|
3,143,287
|
$264.60
|
$831,713,740
|
-0.19% (-5,880)
|
-0.01%
|
|
2024 Q4
|
2.91%
|
3,149,167
|
$253.71
|
$798,975,160
|
-2.98% (-96,623)
|
-0.09%
|
|
2024 Q3
|
3.82%
|
3,245,790
|
$316.74
|
$1,028,071,525
|
+0.59% (+18,905)
|
+0.02%
|
|
2024 Q2
|
4.47%
|
3,226,885
|
$373.65
|
$1,205,725,580
|
+369.64% (+2,539,794)
|
+3.52%
|
|
2024 Q1
|
0.92%
|
687,091
|
$346.72
|
$238,228,192
|
new
|
+0.92%
|
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
* Estimated cost basis: based on "Reported price*" (not earlier than 2013 Q2). Calculation starts from the latest "new buy" activity to the latest "close out" activity (if any).
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.